DISSEMINATED SUPERFICIAL ACTINIC POROKERATOSIS

This adverse event was reported 12 times

These drugs are most commonly taken by patients reporting DISSEMINATED SUPERFICIAL ACTINIC POROKERATOSIS:

# Drug Count
0 CAPECITABINE 2
1 CYCLOSPORINE 2
2 PACLITAXEL 2
3 PACLITAXEL (AIBUMIN-BOUND) 2
4 PREDNISOLONE 2
5 PREDNISOLONE ORAL 2
6 PREDNISOLONE ORAL SOLUTION 2
7 ASFOTASE ALFA 1
8 CETIRIZINE HYDROCHLORIDE 1
9 DUPILUMAB 1
See all common drugs associated with DISSEMINATED SUPERFICIAL ACTINIC POROKERATOSIS

DISSEMINATED SUPERFICIAL ACTINIC POROKERATOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 MIRVETUXIMAB SORAVTANSINE 1 0.0006
1 TEZEPELUMAB-EKKO 1 0.0001
2 ASFOTASE ALFA 1 0.0001
3 NIFEDIPINE 1 0.0000
4 CAPECITABINE 2 0.0000
5 PACLITAXEL 2 0.0000
6 CYCLOSPORINE 2 0.0000
7 UPADACITINIB 1 0.0000
8 PREDNISOLONE ORAL SOLUTION 2 0.0000
9 FAMOTIDINE 1 0.0000
See all drugs enriched for association with DISSEMINATED SUPERFICIAL ACTINIC POROKERATOSIS